Development of functionally selective agonists as novel therapeutic agents

Research output: Contribution to journalReview article

21 Scopus citations

Abstract

Traditionally, drug selectivity has been attributed solely to differential affinity for different receptor subtypes. Recent experimental evidence suggests that, in addition to receptor subtype selectivity, drugs may be selective for individual signaling pathways coupled to a single receptor subtype. This 'functional selectivity' holds the promise of improved therapeutic selectivity and reduced adverse effects.

Original languageEnglish (US)
Pages (from-to)421-428
Number of pages8
JournalDrug Discovery Today: Therapeutic Strategies
Volume3
Issue number4
DOIs
StatePublished - Jun 1 2006

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Development of functionally selective agonists as novel therapeutic agents'. Together they form a unique fingerprint.

Cite this